Board Resolution Template Uk

BOARD RESOLUTION AND COMMERCIAL ENGAGEMENT AUTHORIZATION

DOCUMENT CONTROL DATA

• Document Identifier: BR-UK-2024-ENG-001
• Effective Date: [Effective Date]
• Version: 1.0 (Final Enforceable Release)
• Governing Legislation: Companies Act 2006 (England and Wales)
• Corporate Entity: [Company Full Legal Name] (Company Registration No: [Company Registration Number])

---

STATUTORY AND LEGAL COMPLIANCE NOTICE

NOTICE: This document constitutes a formal corporate record and commercial authorization governed by the provisions of the United Kingdom Companies Act 2006 (the "Act") and the Company’s Articles of Association. This resolution incorporates both the formal minutes/written resolutions of the Board of Directors exercising statutory powers under Sections 171 through 177 and Section 44 of the Act, and the exhaustive substantive contractual terms governing the underlying commercial transaction authorized herein. Directors participating in this resolution must ensure full compliance with their statutory general duties, notably Section 172 (Duty to promote the success of the company) and Section 177 (Duty to declare an interest in a proposed transaction or arrangement). If independent legal or tax advice is required, it must be obtained prior to the execution of this instrument.

---

PARTIES AND RECITALS

This Board Resolution and Commercial Authorization Instrument (the "Instrument") is made and entered into as of [Effective Date], by and between the following corporate entities:

1. [Company Full Legal Name], a private company limited by shares, incorporated and registered in England and Wales under Company Registration Number [Company Registration Number], having its registered office situated at [Company Principal Registered Address] (the "Company"); and
2. [Client Full Legal Name], a company incorporated and registered in [Jurisdiction of Counterparty], under Company Registration Number [Counterparty Registration Number], having its registered office situated at [Counterparty Principal Registered Address] (the "Counterparty" or "Client").

RECITALS

WHEREAS: A. The Board of Directors of the Company (the "Board") has reviewed the commercial objectives, operational requirements, and financial viability of entering into a strategic commercial engagement with the Counterparty. B. The directors have evaluated the commercial terms set out herein in accordance with their fiduciary and statutory duties under the Act, having specific regard to Section 172 of the Act, and have determined in good faith that entering into the engagement on the terms set forth herein is in the best interests of the Company and its members as a whole. C. Each Director has declared the nature and extent of any direct or indirect interest in the proposed transaction in compliance with Section 177 and Section 182 of the Act and the Company's Articles of Association, and any director with an interest has either abstained or been authorized to vote as permitted by the Articles. D. The Board wishes to formally resolve to approve, adopt, and execute the commercial engagement upon the substantive operational and legal terms exhaustively set forth in Section 4 below, and to authorize designated officers of the Company to execute all relevant instruments pursuant to Section 44 of the Act.

---

OPERATIVE RESOLUTIONS AND COMMERCIAL TERMS

IT IS HEREBY UNANIMOUSLY RESOLVED by the Board of Directors of the Company as follows:

1. Corporate Authorizations and Statutory Declarations

1.1. Approval of Transaction: The terms, conditions, and subject matter of the engagement with the Counterparty, as set out in this Instrument, be and are hereby formally approved in all respects. 1.2. Declaration of Directors' Interests: It is noted and recorded that, pursuant to Section 177 of the Companies Act 2006 and the Company's Articles of Association, the Directors have each declared their interests (if any) in the proposed transaction, and it is confirmed that no conflict exists that would disqualify any director from quorum or voting consideration, or alternatively, that such interest has been fully sanctioned in accordance with the Articles. 1.3. Execution Authority under Section 44: In accordance with Section 44 of the Companies Act 2006, any one Director (in the presence of an attesting witness) or any two Directors, or one Director and the Company Secretary, or any designated Authorized Signatory identified herein, be and is hereby authorized to execute this Instrument, any related schedules, deeds, certificates, or notices in the name and on behalf of the Company. 1.4. Delivery of Deed / Contract: The Company is authorized to deliver this Instrument immediately upon its formal execution as binding on the Company.

---

2. Scope of Services and Engagement

2.1. Appointment and Obligations: The Counterparty hereby formally engages the Company, and the Company agrees, to render the professional and technical services detailed in the statement of work attached hereto or specified herein (the "Services"). 2.2. Performance Standards: The Company shall perform the Services with reasonable skill and care, consistent with established industry standards, using personnel possessing suitable qualifications, training, and experience. 2.3. Deliverables and Milestones: The Company shall use commercially reasonable endeavors to provide the deliverables ("Deliverables") in accordance with the project schedule, timelines, and milestones mutually agreed upon in writing by the parties. 2.4. Client Cooperation and Input: The Counterparty shall provide the Company, without undue delay, with all access, facilities, documentation, approvals, and data reasonably requested by the Company to execute the Services. The Company shall not be liable for any failure or delay arising from the Counterparty’s failure to provide necessary input or instructions. 2.5. Change Management: Any modification to the scope, nature, or volume of the Services must be documented in a written Change Order signed by authorized representatives of both parties, setting out the associated impact on fees and timelines.

---

3. Compensation, Payment Terms, and Late Interest

3.1. Contract Price: The Counterparty shall pay the Company the total contract sum of [Amount in USD] (or its direct equivalent in GBP: [Amount in GBP]), payable against agreed milestones or on a time-and-materials basis as specified in this Instrument. 3.2. Invoicing Frequency: Invoices shall be raised by the Company on a monthly basis in arrears, or upon the verified completion of discrete milestones. 3.3. Settlement Period: All undisputed invoices must be paid in full by electronic bank transfer to the account nominated by the Company within thirty (30) calendar days from the date of issuance of the invoice. 3.4. Taxes: All sums payable under this Instrument are exclusive of Value Added Tax (VAT) and any applicable sales, turnover, or withholding taxes, which shall be added to the invoice at the prevailing statutory rate and paid by the Counterparty. 3.5. Late Payment Interest: If the Counterparty fails to make any payment due to the Company under this Instrument by the due date, the Counterparty shall pay interest on the overdue sum from the due date until payment of the overdue sum, whether before or after judgment. Interest under this clause shall accrue daily at the statutory rate prescribed under the Late Payment of Commercial Debts (Interest) Act 1998 (being 8% per annum above the Bank of England base rate), or, in the alternative, at 4% per annum above the base rate of Barclays Bank PLC where the statutory regime is inapplicable. 3.6. Disputed Invoices: The Counterparty must notify the Company in writing of any bona fide dispute concerning an invoice within fourteen (14) calendar days of receipt, failing which the invoice shall be deemed conclusively accepted. Undisputed amounts must be paid within the standard thirty (30) day payment window.

---

4. Term, Termination, and Cure Period

4.1. Term: This engagement shall commence on [Effective Date] and shall continue in full force and effect until [Termination Date], or until the Services are fully completed, unless terminated earlier in accordance with this Section 4. 4.2. Termination for Convenience: Either party may terminate this engagement without cause upon providing not less than sixty (60) calendar days' prior written notice to the other party. In the event of such termination, the Counterparty shall pay the Company for all Services performed, work-in-progress, and non-cancellable commitments incurred up to the effective date of termination. 4.3. Termination for Material Breach: Either party may terminate this engagement with immediate effect by written notice if the other party commits a material breach of any term of this Instrument and, if such breach is capable of remedy, fails to remedy that breach within thirty (30) calendar days of being notified in writing to do so (the "Cure Period"). 4.4. Termination for Insolvency: Either party may terminate this Instrument immediately upon written notice if the other party: 4.4.1. Suspends, or threatens to suspend, payment of its debts or is unable to pay its debts as they fall due within the meaning of section 123 of the Insolvency Act 1986; 4.4.2. Enters into administration, administrative receivership, liquidation (voluntary or compulsory), or an arrangement or composition with its creditors; 4.4.3. Ceases, or threatens to cease, to carry on all or substantially the whole of its business. 4.5. Accrued Rights: Termination of this Instrument shall not prejudice any rights, remedies, or liabilities of the parties that have accrued up to the date of termination.

---

5. Intellectual Property Ownership and Assignments

5.1. Background IP: Each party retains absolute ownership of all intellectual property rights owned by it or licensed to it prior to the Effective Date, or developed independently of the Services ("Background IP"). Neither party obtains any right, title, or interest in or to the Background IP of the other party, save for the limited non-exclusive licenses expressly granted herein. 5.2. Foreground Deliverables: Subject to full, final, and unconditional payment of all sums due under Section 3, the Company hereby assigns to the Counterparty, with full title guarantee, all right, title, and interest in and to the bespoke deliverables created specifically for the Counterparty under this Instrument ("Foreground IP"), excluding any incorporated Background IP or standard methodologies. 5.3. Pre-Existing Assets and Tools: To the extent that any Foreground IP incorporates any Company Background IP, proprietary tools, scripts, processes, or reusable libraries, the Company hereby grants to the Counterparty a non-exclusive, perpetual, worldwide, royalty-free license to use, reproduce, and display such Background IP solely as integrated within the Deliverables for the Counterparty's internal business operations. 5.4. Work Made for Hire Disclaimer: The parties expressly acknowledge that the doctrine of "work made for hire" under foreign jurisdictions is inapplicable, and all rights, assignments, and transfers of copyright and industrial designs are governed strictly under the provisions of the Copyright, Designs and Patents Act 1988 (CDPA 1988) and this Section 5.

---

6. Mutual Confidentiality and Non-Disclosure

6.1. Definition of Confidential Information: "Confidential Information" means all information of a confidential or proprietary nature (whether written, oral, visual, or electronic) disclosed by one party ("Disclosing Party") to the other party ("Receiving Party"), including but not limited to business plans, financial records, client lists, algorithms, source code, trade secrets, and the terms of this Instrument. 6.2. Standard of Protection: The Receiving Party undertakes to maintain the Confidential Information in strict confidence and shall exercise the same degree of care as it uses for its own confidential information, being not less than a reasonable degree of care. 6.3. Permitted Use: The Receiving Party shall use the Disclosing Party's Confidential Information solely to exercise its rights and perform its obligations under this Instrument. 6.4. Exceptions: Confidential Information does not include information that: 6.4.1. Is or becomes publicly known through no breach of this Instrument by the Receiving Party; 6.4.2. Was already in the Receiving Party’s possession without restriction prior to disclosure; 6.4.3. Is received from an independent third party without violation of any non-disclosure duty; or 6.4.4. Is independently developed without reference to or reliance upon the Confidential Information. 6.5. Compelled Disclosure: A party may disclose Confidential Information to the extent required by an order of a court of competent jurisdiction or regulatory body, provided it gives prompt written notice to the Disclosing Party (where legally permissible) to enable the Disclosing Party to seek a protective order. 6.6. Survival: The obligations set forth in this Section 6 shall survive termination or expiration of this Instrument for a period of five (5) years, provided that trade secrets shall remain confidential indefinitely.

---

7. Representations and Warranties

7.1. Mutual Representations: Each party represents and warrants to the other that: 7.1.1. It is duly incorporated, validly existing, and in good standing under the laws of its jurisdiction of incorporation; 7.1.2. It has full corporate power, capacity, and authority to enter into and perform its obligations under this Instrument; 7.1.3. The execution, delivery, and performance of this Instrument has been duly authorized by all necessary corporate and board approvals; and 7.1.4. This Instrument forms a legal, valid, and binding obligation enforceable against it in accordance with its terms. 7.2. Company Warranties: The Company warrants that the Services shall be performed in a professional manner conforming to recognized standard practices, and that the Deliverables (excluding Counterparty-supplied data) do not knowingly infringe the intellectual property rights of any third party. 7.3. Exclusion of Implied Terms: To the fullest extent permitted by law, all other representations, warranties, conditions, or terms implied by statute, common law, custom, trade usage, or course of dealing (including conditions of satisfactory quality or fitness for a particular purpose) are expressly excluded.

---

8. Limitation of Liability and Indemnification

8.1. Uncapped Liabilities: Nothing in this Instrument shall limit or exclude either party's liability for: 8.1.1. Death or personal injury caused by its negligence; 8.1.2. Fraud or fraudulent misrepresentation; 8.1.3. Breach of the terms implied by section 12 of the Sale of Goods Act 1979 or section 2 of the Supply of Goods and Services Act 1982; or 8.1.4. Any other liability that cannot be limited or excluded under applicable English law. 8.2. Consequential Loss Exclusion: Subject to Clause 8.1, neither party shall under any circumstances be liable to the other, whether in contract, tort (including negligence), breach of statutory duty, or otherwise, for: 8.2.1. Loss of profit, revenue, or business opportunities; 8.2.2. Loss of anticipated savings or goodwill; 8.2.3. Loss of or corruption to data or software; or 8.2.4. Any indirect, special, incidental, or consequential loss or damage. 8.3. Aggregate Liability Cap: Subject to Clause 8.1 and Clause 8.2, each party's total aggregate liability arising out of or in connection with this Instrument, whether in contract, tort (including negligence), indemnity, or otherwise, shall be strictly limited to one hundred percent (100%) of the total fees paid or payable by the Counterparty to the Company under this Instrument in the twelve (12) months immediately preceding the event giving rise to liability. 8.4. Mutual Indemnification: 8.4.1. Company Indemnity: The Company shall indemnify the Counterparty against direct damages awarded by a court of competent jurisdiction arising out of any third-party claim that the unmodified Deliverables infringe the intellectual property rights of that third party. 8.4.2. Counterparty Indemnity: The Counterparty shall indemnify the Company against any claims, losses, or costs arising out of the Counterparty’s breach of applicable laws, provision of infringing materials, or unauthorized modification of the Deliverables.

---

9. Dispute Resolution and Escalation

9.1. Executive Escalation: In the event of any dispute, controversy, or claim arising out of or relating to this Instrument, the parties shall first attempt to resolve the matter through informal consultations between their designated senior executives (Chief Executive Officer, Managing Director, or equivalent). 9.2. Mediation: If the dispute is not resolved within twenty-one (21) calendar days of referral to senior executives, the parties shall attempt to settle it by mediation in accordance with the Centre for Effective Dispute Resolution (CEDR) Model Mediation Procedure. 9.3. Arbitration / Litigation: If the dispute is not settled via mediation within forty-five (45) calendar days following commencement of mediation: 9.3.1. The dispute shall be referred to and finally resolved by arbitration under the Rules of the London Court of International Arbitration (LCIA), which Rules are deemed incorporated by reference into this clause; 9.3.2. The number of arbitrators shall be one (1); 9.3.3. The seat, or legal place, of arbitration shall be London, England; and 9.3.4. The language used in the arbitral proceedings shall be English. 9.4. Injunctive Relief: Nothing in this Section 9 shall preclude either party from seeking preliminary injunctive relief, freezing orders, or protective measures from the courts of England and Wales to restrain imminent breach or preserve confidential information.

---

10. Governing Law and Jurisdiction

10.1. Governing Law: This Instrument and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the laws of England and Wales. 10.2. Jurisdiction: Subject to the arbitration provisions set forth in Section 9, each party irrevocably agrees that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute, enforcement action, or claim arising out of or in connection with this Instrument.

---

11. Miscellaneous Administrative Provisions

11.1. Severability: If any provision or part-provision of this Instrument is or becomes invalid, illegal, or unenforceable, it shall be deemed modified to the minimum extent necessary to make it valid, legal, and enforceable. If such modification is not possible, the relevant provision or part-provision shall be deemed deleted. Any modification or deletion shall not affect the validity and enforceability of the rest of this Instrument. 11.2. Counterparts: This Instrument may be executed in any number of counterparts, each of which when executed and delivered shall constitute a duplicate original, but all the counterparts shall together constitute the one instrument. Transmission of an executed counterpart of this Instrument by electronic signature or PDF email shall take effect as delivery of an original. 11.3. Entire Agreement: This Instrument constitutes the entire agreement between the parties and supersedes and extinguishes all previous agreements, promises, assurances, warranties, representations, and understandings between them, whether written or oral, relating to its subject matter. 11.4. Third Party Rights: A person who is not a party to this Instrument shall not have any rights under the Contracts (Rights of Third Parties) Act 1999 to enforce any term of this Instrument. 11.5. Variation: No variation of this Instrument shall be effective unless it is in writing and signed by the parties (or their authorized representatives). 11.6. Waiver: No failure or delay by a party to exercise any right or remedy provided under this Instrument or by law shall constitute a waiver of that or any other right or remedy.

---

EXECUTION AND FORMAL SIGNATURE BLOCKS

IN WITNESS WHEREOF, the parties hereto have caused this Board Resolution and Commercial Engagement Authorization to be duly executed by their respective authorized signatories as of the date first written above.

FOR [PARTY A / COMPANY NAME]:
Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Company Legal Name]
Date: [Date]

FOR [PARTY B / CLIENT / COUNTERPARTY]:
Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Date: [Date]

---

STEP-BY-STEP EXECUTION AND FILING GUIDE

This operational checklist outlines how to complete, execute, and archive this Board Resolution and Commercial Agreement under English corporate law.

[Draft Instrument] ──> [Verify Authority] ──> [Circulate via DocuSign] ──> [Minute Book Archival]
       │                       │                          │                          │
Fill bracketed          Review Articles of         Ensure eIDAS-compliant      Retain for 10+ years
fields & amounts        Association (s.177 CA06)    audit trail (s.44 CA06)     (s.248 & 355 CA 2006)

Step 1: Completing Document Variables

1. Open the document in Microsoft Word, Google Docs, or an enterprise Contract Lifecycle Management (CLM) platform.
2. Use global search and replace to update all bracketed placeholders:
   • [Company Full Legal Name] and [Company Registration Number] (verify directly against the Companies House Registry).
   • [Company Principal Registered Address] (must match the registered office registered with Companies House).
   • [Client Full Legal Name], [Jurisdiction of Counterparty], and [Counterparty Registration Number].
   • [Effective Date] and [Termination Date].
   • [Amount in USD] and [Amount in GBP].
   • [Authorized Signatory Name] and [Title / Role] for both parties.

Step 2: Corporate Governance Verification

1. Check Articles of Association: Verify whether the Company operates under the Model Articles for Private Companies Limited by Shares or bespoke Articles. Confirm:
   • Quorum: Ensure that the required number of directors participate in approving the resolution (usually two directors under Model Articles, or one if a sole-director company).
   • Conflict of Interest: If any director has a personal interest in the Counterparty, confirm whether the Articles permit interested directors to vote after declaring their interest under Section 177 of the Companies Act 2006.
2. Written Resolution vs Board Meeting: If executing this as a written resolution rather than at a physical meeting, ensure unanimous written consent is obtained from all eligible directors in accordance with standard governance practices.

Step 3: Formal Execution Protocol (Section 44 Companies Act 2006)

Under English law, the Company may execute this document in one of three statutory ways:

• Option A (Standard Corporate Execution): Signed by two authorized signatories (either two directors, or one director and the company secretary).
• Option B (Sole Director with Witness): Signed by a single director in the physical presence of an independent adult witness who attests the signature.
• Option C (Authorized Attorney/Agent): Signed by an officer specifically empowered under an existing corporate Power of Attorney.

Step 4: Digital Signatures and Electronic Execution

1. This instrument can be executed using advanced electronic signatures via DocuSign, Adobe Sign, or HelloSign.
2. Under the Law Commission’s statement on electronic execution and the UK Electronic Communications Act 2000, electronic signatures are legally valid and enforceable provided there is an intention to authenticate.
3. Ensure the e-signature system generates a Certificate of Completion or Audit Trail capturing IP addresses, timestamps, and identity verification.

Step 5: Statutory Filing and Record Retention

1. Companies House Filing: Ordinary board resolutions approving general commercial agreements do not need to be filed with Companies House (unlike special shareholder resolutions or changes to company officers/articles).
2. Statutory Minute Book Retention: Under Section 248 and Section 355 of the Companies Act 2006, the Company must keep records of all board minutes and resolutions for a minimum statutory period of ten (10) years from the date of adoption.
3. Store the fully signed counterpart in the Company's central legal minute book (either physical binder or secure digital corporate governance repository). Ensure accounting and contract administration teams receive executed copies to reconcile milestone payments and deliverables.